Showing posts with label cancer. Show all posts
Showing posts with label cancer. Show all posts

1 December 2021

NHS backlogs and waiting times in England

NHS backlogs and waiting times in England
NAO 1 December 2021
  • This report looks in detail at backlogs and waiting times for elective and cancer care in the NHS in England. It explains how the current increased backlogs and waiting times have arisen, including the impact of the COVID-19 pandemic.
  • The report sets out:
    • how waiting times performance for elective and cancer care are tracked in the NHS, and how long patients have been waiting relative to the performance standards;
    • the causes of increasing longer waits before the pandemic and the disruption caused by the pandemic; and
    • the steps the Department and NHSE&I have already taken to address the increasing backlogs and waiting times, and the constraints and challenges the NHS faces in making a full recovery.
  • The NAO intends to follow this report with a second one, which will describe the NHS’s plans to improve this situation and evaluate its early progress.

29 March 2021

Social Prescribing for cancer patients

Social prescribing for cancer patients: A guide for primary care networks
MacMillan Cancer Support 29 March 2021
  • This guide supports Primary Care Networks and the wider workforce to understand the important role Social Prescribers play in supporting people living with cancer.

30 September 2020

Cancer in the UK 2020: Socio-economic deprivation

Cancer in the UK 2020: Socio-economic deprivation
Cancer Research UK September 2020
  • This report examines the link between socio-economic deprivation and cancer. 
  • “People from more deprived areas are not only more likely to get cancer, they’re more likely to be diagnosed at a late stage for certain cancer types, and have trouble accessing cancer services.“
  • Full report here.

4 August 2020

CancerData

CancerData https://www.cancerdata.nhs.uk/

19 December 2019

Cancer Care Map

Cancer Care Map
"a simple, online resource that aims to help people find cancer-related services in their local area wherever you are in the UK."

29 November 2019

Cancer survival: index for CCGs

Cancer survival: index for Clinical Commissioning Groups
PHE 29 November 2019
  • One-year cancer survival (all-cancers combined, 3 cancers combined, breast, colorectal and lung) in CCGs in England for patients diagnosed in the period 2002 to 2017 and followed up to 2018. 
  • One-, 5- and 10-year index of cancer survival estimates are also available by Sustainability and Transformation Partnerships and Cancer Alliances.

28 November 2019

Some patients with suspected cancer fail to attend referral appointments – we found out why

Some patients with suspected cancer fail to attend referral appointments – we found out why
The Conversation 28 November 2019
  • A study has found evidence that more than 5% patients do not attend their urgent referral appointments. The researchers used a statistical study of more than 100,000 patients who had received an urgent referral for suspected cancer, and an interview study with GPs and with patients who had cancelled or not attended their urgent referral appointment to try to understand why.

31 October 2019

Clinically-led Review of NHS Access Standards - progress report

Clinically-led Review of NHS Access Standards
NHS England 31 October 2019
  • This is a progress report on the review of NHS access standards in urgent and emergency care, mental health services, cancer care and elective care. It
    • 1. recaps on the proposed new standards in each of the four areas, the rationale for those proposals, and update on what we are finding through testing.
    • 2. sets out the planned next steps in terms of continuing with testing and
    • 3. outlines the timetable for making final recommendations and implementing any agreed new standards.
  • "For urgent and emergency care, where the field testing has been running longer and will be able to conclude sooner, the intention is to support the NHS to implement any changes from 1 April 2020. For elective care and cancer, implementation is likely to be during mid 2020/21. In mental health, where completely new standards are being proposed, implementation will be to a longer timeframe, as testing is likely to continue in 2020/21 to ensure that the introduction of standards in these areas is sustainable. All timelines are subject to change and government agreement."
  • The review is working in tandem with the National review of access to general practice services in England

16 October 2019

Report of The Independent Review of Adult Screening Programmes in England

Report of The Independent Review of Adult Screening Programme in England
NHS England 16 October 2019
  • The review makes a number of recommendations regarding screening in England around governance, IT systems, uptake and delivery, performance, financial incentives, creating capacity to change, improving audit and research.
  • A key change is that NHS England should take responsibility for the delivery of all screening programmes, integrating the delivery of targeted and population screening previously split between NHS England and PHE.

19 September 2019

8 August 2019

CancerData dashboard

CancerData dashboard
NHS England and Public Health England
  • The CancerData dashboard brings together data across the whole cancer pathway at CCG, provider and national levels.

1 August 2019

10 top tips for primary care: Social prescribing

10 top tips for primary care: Social prescribing
Macmillan Cancer Support 2019
  • Ten top tips to help primary care professionals support patients at every stage of the cancer pathway. The tips are designed to showcase best practice and offer practical advice for your role.

30 April 2019

Cancer in the UK 2019

Cancer in the UK 2019
Cancer Research UK April 2019
  • This report summarises the current state of cancer in the UK, recognising where progress has been made, and highlighting the challenges that we continue to face. It includes national data on Prevention, Early diagnosis, Treatment and Data and research.